Medical Advocates

HCV Infection/Disease
  North American Seroprevalence/Incidence Studies/
National Challenges

Canada
United States



 










 

HCV Epidemiology Main Page
Main New/Newsworthy  Home Page      

Last Update:  April 13, 2018
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

Canada
 

    Videos
 
 

Deal with it: Untold Stories of Hepatitis C in Canada

 
 

     Journal Papers, Abstracts, and Commentaries
 

 

Increasing Hepatitis C Virus Knowledge Through an Evidence-Based Educational Intervention.
Koman D.
Gastroenterol Nurs. 2018 Mar/Apr;41(2):95-102.
Abstract

FULL-TEXT ARTICLE
Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.
Bolotin S, Feld JJ, Garber G,
PLoS One. 2018 Jan 23;13
Paper

Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients.
Aspinall AI, Shaheen AA, Kochaksaraei GS, HS. et al
CMAJ Open
. 2018 Jan 5;6(1):E12-E18.

Abstract

Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer.
Studaway A, Ojha RP, Brinkman TM, et a;
Cancer. 2017 Jul 25.

Abstract

The impact of hepatitis C virus infection on 90-day outcomes following major orthopaedic surgery: a propensity-matched analysis.
Chowdhury R, Chaudhary MA, Sturgeon DJ,  et al
Arch Orthop Trauma Surg. 2017 Jul 3
Abstract

Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens.
Puenpatom A, Hull M, McPheeters J, Schwebke K.
Clin Drug Investig. 2017 Apr 6
Abstract

AGA Institute Clinical Practice Update: Care of Patients Who Have Achieved a Sustained Virologic Response (SVR) Following Antiviral Therapy for Chronic Hepatitis C Infection.
Jacobson IM, Lim JK, Fried MW.
Gastroenterology. 2017 Mar 23.
Abstract

FULL-TEXT ARTICLE
Treating Medicaid patients with hepatitis C: clinical and economic impact
Younossi Z, Gordon SC, Ahmed A, et al  
Am J Manag Care. 2017 Feb;23(2):107-112.
Paper

A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, Canada.
Greenaway C, Azoulay L, Allard R, et al
BMC Infect Dis
. 2017 Feb 13;17(1):140.
Abstract

FULL-TEXT ARTICLE
Hepatitis C Virus: A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy.
Lynch SM, Wu GY.
J Clin Transl Hepatol. 2016 Dec 28;4(4):310-319
Paper

Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare.
Jung J, Feldman R
|J Racial Ethn Health Disparities
. 2016 Dec 7.
Abstract

Differential expression of microRNAs in hepatitis C virus mediated liver disease between African Americans and Caucasians: Implications for racial health disparities.
Devhare PB, Steele R, Bisceglie AM, et al  
Gene Expr
. 2016 Oct 19.
Abstract

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care.
Younossi ZM, Park H, Dieterich D,  et al
Medicine (Baltimore). 2016 Oct;95(41
Abstract

FULL-TEXT PDF ARTICLE
The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
Janjua NZ, Kuo M, Yu A, Alvarez M, et al
EBioMedicine
. 2016 Aug 25.
Paper

Hospitalizations in immigrants and non-immigrants diagnosed with chronic hepatitis C infection in Quebec.
Kamstra R, Azoulay L, Steele R, Klein MB, Greenaway C.
Clin Infect Dis
. 2016 Aug 7.
Abstract

FULL-TEXT ARTICLE
Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort. h
Janjua NZ, Yu A, Kuo M, et al
BMC Infect Dis
. 2016 Jul 19;16:334.
Paper

Influence of female sex on hepatitis C virus infection progression and treatment outcomes.
Corsi DJ, Karges W, Thavorn K, et al
Eur J Gastroenterol Hepatol
. 2016 Jan 7
Abstract

Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993-2011.
Kuo M, Janjua NZ, Burchell AN, Buxton JA, et al
Am J Public Health. 2015 Jun 11:e1-e7.
Abstract

Increased eligibility for treatment of chronic hepatitis C infection with shortened duration of therapy: Implications for access to care and elimination strategies in Canada.
Borgia SM, Rowaiye A.
Can J Gastroenterol Hepatol
. 2015 Apr;29(3):125-9
Abstract

Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement.
Artenie AA, Jutras-Aswad D, Roy É, et al

J Viral Hepat
. 2015 Jan 14.
Abstract

Cost-effectiveness of screening for hepatitis C in Canada.
Wong WW, Tu HA, Feld JJ, et al
CMAJ
. 2015 Jan 12. pii: cmaj.140711.
Abstract

Burden of disease and cost of chronic hepatitis C infection in Canada.
Myers RP, Krajden M, Bilodeau M,  et al
Can J Gastroenterol Hepato
l
. 2014 May;28(5):243-50.
Abstract

Accuracy of physician reporting in routine public health surveillance for hepatitis C virus infection
Jochem K, Leclerc P, Maurais E,  et al
Public Health Rep. 2014 Jan;129(1):64-72.
Abstract

The Second Canadian Symposium on Hepatitis C Virus: A call to action.
Grebely J, Bilodeau M, Feld JJ,  et al
Can J Gastroenterol. 2013 Nov;27(11):627-32
Abstract

The epidemiology of hepatitis C in a Canadian Indigenous population.
Uhanova J, Tate RB, Tataryn DJ, Minuk GY.
Can J Gastroenterol. 2013 Jun;27(6):340-39.
Abstract

Hepatitis C Testing, Infection, and Linkage to Care Among Racial and Ethnic Minorities in the United States, 2009-2010.
Tohme RA, Xing J, Liao Y, et al
Am J Public Health. 2012 Nov 15.
Abstract

Factors associated with HCV antiviral treatment uptake among participants of a community-based HCV programme for marginalized patients.
Charlebois A, Lee L, Cooper E, et al
J Viral Hepat
. 2012 Dec;19(12):836-42.
Abstract

Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users.
Roy E, Arruda N, Leclerc P,  et al

Drug Alcohol Depend
. 2012 Jun 12.
Abstract

FULL-TEXT ARTICLE
Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs.
Pilon R, Leonard L, Kim J, et al
PLoS One
. 2011;6(7):e22245
Paper

Health Utilities and Psychometric Quality of Life in Patients With Early- and Late-Stage Hepatitis C Virus Infection.
Hsu PC, Federico CA, Krajden M,

J Gastroenterol Hepatol
.
2011 Jun 16
Abstract

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Cornberg M, Razavi HA, Alberti A, et al

Liver Int
.
2011 Jul;31 Suppl 2:30-60.
Abstract

Health care costs associated with hepatitis C: A longitudinal cohort study.
Krajden M, Kuo M, Zagorski B, et al
Can J Gastroenterol
. 2010 Dec;24(12):717-26
Abstract

 

United States
 

     Books
 
  Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report.
Committee on a National Strategy for the Elimination of Hepatitis B and C, Board on Population Health and Public Health Practice,
Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine; Buckley GJ, Strom BL, editors. Washington (DC):
National Academies Press (US); 2016 Jun 0
Book

     Internet Documents/Videos

 
  INTERNET DOCUMENT
Screening for Hepatitis C Virus Infection in Adults

U.S. Preventive Services Task Force Recommendation Statement
June 25, 2013
Guidelines

Managing Denials Of Hepatitis C Prescriptions
 

     Journal Papers, Abstracts, and Commentaries
 

 
FULL-TEXT ARTICLE
Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
Facente SN, Grebe E, Burk K,  et al
PLoS One. 2018 Apr 11;13(4):e0195575.
Paper

Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.
Barocas JA, Tasillo A, Eftekhari Y
Clin Infect Dis
. 2018 Feb 6.
Abstract

Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.
Zibbell JE, Asher AK, Patel RC, et al

 Am J Public Health
. 2018 Feb;108(2):175-181.
Abstract

Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.
Barocas JA, Tasillo A, Eftekhari Yazdi G, . et al
Clin Infect Dis. 2018 Feb
Abstract

Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.
Barocas JA, Tasillo A, Eftekhari Yazdi G,
Clin Infect Dis. 2018 Feb 6
Abstract

Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.
Zibbell JE, Asher AK, Patel RC,  et  al
Am J Public Health
. 2018 Feb;108(2):
Abstract

FULL-TEXT ARTICLE
Low hepatitis C antibody screening rates among an insured population of Tennessean Baby Boomers.
Carlucci JG, Farooq SA, Sizemore L, et al
PLoS One. 2017 Nov 30;12(11):e0188624.
Paper

Towards the Elimination of Hepatitis C in the United States.
Saab S, Le L, Saggi S, Sundaram V, Tong M
Hepatology. 2017 Nov 2
Abstract

Improving patient access to hepatitis C virus treatment.
McLaughlin MM, Marx KT, et alJ
Am Pharm Assoc (2003). 2017 Nov 16.
Abstract

FULL-TEXT ARTICLE
Local specialty pharmacy and specialty clinic collaboration assists access to hepatitis C direct-acting antivirals.
Zhu J, Hazen RJ, Joyce C, Delpino A
J Am Pharm Assoc
(2003)
. 2017 Nov 16

Paper

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial.
Kattakuzhy S, Gross C, Emmanuel B, et al
Ann Intern Med. 2017 Aug 8.
Abstract

Scaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic.
Fraser H, Zibbell J, Hoerger T,  et al
Addiction. 2017 Jul 22.
Abstract

Silence Surrounding Hepatitis C Status in Risk Relationships Among Rural People Who Use Drugs.
Hofmeister MG, Havens JR, Young AM.
J Prim Prev
.
2017 Jul 21.
Abstract

In an Era of Highly Effective Treatment, Hepatitis C Screening of the General Population of the United States for Hepatitis C Should be Considered.
Younossi Z, Blissett D, Blissett R,  et al
Liver Int. 2017 Jul 18.
Abstract

Racial Disparities in Hepatitis C Treatment Eligibility.
Sims OT, Pollio DE, Hong BA, North CS.
Ann Hepatol
. 2017 Aug 1;16(4):530-537.
Abstract

Evaluating a Collaborative Approach to Improve Prior Authorization Efficiency in the Treatment of Hepatitis C Virus.
Dunn EE, Vranek K, Hynicka LM,
Qual Manag Health Care. 2017 Jul/Sep;26(3):136
Abstract

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services For Persons Who Inject Drugs - United States, 2015-2016.
Campbell CA, Canary L, Smith N, et al
 
Am J Transplant
. 2017 Jul;17(7):1945-1948.
Abstract

Hepatitis C Virus Prevalence in Egyptian Americans in Southern California.
Saab S, Viramontes MR, Chalifoux SL,  
J Clin Gastroenterol. 2017 Jun 14
Abstract

Incidence of Hepatitis C Virus Infection in the Human Immunodeficiency Virus Outpatient Study Cohort, 2000-2013.
Samandari T, Tedaldi E, Armon C, et al  
Open Forum Infect Dis. 2017 Jun 10;4(2):ofx076.

Abstract

Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations.
Moreno GA, Wang A, Sánchez González Y, et al  
Value Health
. 2017 Jun;20(6):736-744.
Abstract

Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China.
Wu E, Yang M, Rao H, et al
Dig Dis Sci. 2017 Jun 1.
Abstract

FULL-TEXT ARTICLE
Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845
Vijgen L, Thys K, Vandebosch A,et al  
Virol J. 2017 May 31;14(1):101
Pap
er

FULL-TEXT ARTICLE
Identifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approach.
Stopka TJ, Goulart MA, Meyers DJ, et al 
BMC Infect Dis
. 2017 Apr 20;17
Paper

Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
Rosenberg ES, Hall EW, Sullivan PS, et al
Clin Infect Dis. 2017 Apr 26.
Abstract

Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis.
Dolatimehr F, Karimi-Sari H, Rezaee-Zavareh MS, et al
Daru
. 2017 Apr 20;25(1):11
Abstract

Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens.
Puenpatom A, Hull M, McPheeters J, Schwebke K.

Clin Drug Investig
. 2017 Apr 6.
Abstract

Barriers to Hepatitis C Screening in a Minority Population: A Comparison of Hepatitis C and Human Immunodeficiency Virus Screening Rates at a Community STD Clinic in Miami, Florida.
Feldman EB, Balise R, Schiff E,  et al
J Community Health. 2017 Mar 28
Abstract

Improving Support and Education of Low Income Baby Boomers Diagnosed with Chronic Hepatitis C Virus Infection through Universal Screening.
Turner BJ, Craig K, Makanji VS, et al
J Clin Nurs. 2017 Mar 15.
Abstract

Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.
Moon AM, Green PK, Berry K, Ioannou GN.
Aliment Pharmacol Ther. 2017 Mar 8.
Abstract

Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions
Chan J, Chung RT.
Clin Pharmacol Drug Dev. 2017 Mar;6(2):147-163.
Abstract

Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis and Linkage to Care in High-Risk Populations.
Ford MM, Johnson N, Rude E, et al
J Public Health Manag Pract. 2017 Jan 30.
Abstract

Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D, Ditah IC, Saeian K, et al
Gastroenterology. 2017 Jan 11.
Abstract

Treatment and characteristics of patients treated for hepatocellular carcinoma (HCC) by physician types in the United States.
S
eal BS, Foltz Boklage SH, Asche CV.
J Clin Oncol. 2012 Feb;30(4_suppl):375.
Abstract

HIV-infected and Uninfected Adults with Non-Genotype 3 Hepatitis C Virus Have Less Hepatic Steatosis than Adults with Neither Infection.
Price JC, Ma Y, Scherzer R, Korn N, et al 
Hepatology
. 2016 Dec 16.
Abstract

FULL-TEXT ARTICLE
National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
Gvinjilia L, Nasrullah M, Sergeenko D,  et al
MMWR Morb Mortal Wkly Rep
. 2016 Oct 21;65(41):1132-1135
.
Paper

Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
Gauthier TP, Moreira E, Chan C, et al
J Am Pharm Asso
c (2003)
. 2016 Sep 22.
Abstract

Patient satisfaction with the clinical pharmacist and prescribers during hepatitis C virus management.
Martin MT, Faber DM.
J Clin Pharm Ther
. 2016 Aug 31.
Abstract

Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease.
Leidner AJ, Chesson HW, Spradling PR, Holmberg SD.
Appl Health Econ Health Policy. 2016 Aug 1
Abstract

FULL-TEXT ARTICLE
Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States and Kentucky, 2011-2014.

Koneru A, Nelson N, Hariri S, Canary L,  et al
MMWR Morb Mortal Wkly
Rep
. 2016 Jul 22;65(28):705-10.
Paper

Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study.
Clements KM, Clark RE, Lavitas P,  et al
J Manag Care Spec Pharm. 2016 Jun;22(6):714-722b.
Abstract

FULL-TEXT ARTICLE
Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
Moreno GA, Mulligan K, Huber C,  et al
Am J Manag Care
. 2016 May;22(6
Paper

HIV and Hepatitis C Virus Screening Practices in a Geographically Diverse Sample of American Community Health Centers.
Mayer KH, Crawford P, Dant L,  et al
AIDS Patient Care
STDS
. 2016 Jun;30(6):237-246.
Abstract

Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study.
Clements KM, Clark RE, Lavitas P,  et al
J Manag Care Spec Pharm
. 2016 Jun;22(6):714-722b.
Abstract

Long-term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the U.S. transplant registry.
Koenig A, Stepanova M, Saab S, et al
Aliment Pharmacol Ther. 2016 Jun 9
Abstract

Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health Level
Seña AC, Willis SJ, Hilton A,  et al
Public Health Rep. 2016 May-Jun;131 Suppl 2:57-64.
Abstract

FULL-TEXT ARTICLE
Coverage for hepatitis C drugs in Medicare Part D.
Jung JK, Feldman R, Cheong C, . et al
Am J Manag Care. 2016 May;22(6 Spec No.):SP220-6.
Paper

FULL-TEXT ARTICLE
Linkage to Care for Suburban Heroin Users with Hepatitis C Virus Infection, New Jersey, USA.
Akyar E, Seneca KH, Akyar S,  et al
Emerg Infect Dis
. 2016 May;22(5):907-9.
Paper

Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013.
Teshale EH, Xing J, Moorman A,  et al
J Viral Hepat
. 2016 May 15
Abstract

Cost-Effectiveness of the Hepatitis C Self-Management Program.
Groessl EJ, Sklar M, Laurent DD, et al
Health Educ Behav
. 2016 May 19

Abstract

FULL-TEXT ARTICLE
Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J, Vellozzi C, Hariri S,  et al
MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):461-6.
Paper

Association of Hepatitis C Virus With Alcohol Use Among U.S. Adults: NHANES 2003-2010.
Taylor AL, Denniston MM, Klevens RM,
Am J Prev Med
. 2016 May
Abstract

Hepatitis C Virus Genotype and Subtype Distribution in Patient Specimens Tested at the University of Texas Medical Branch, Galveston, Between January 2011 and November 2014.
Xie Y, Garza G, Dong J.
Lab Med. 2016 May;47(2):112-118.
Abstract

Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health Level.
Seña AC, Willis SJ, Hilton A, et al
Public Health Rep
. 2016 May-Jun;131(Suppl 2):57-64.
Abstract

Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014.
Coyle C, Kwakwa H, Viner K.
Public Health Rep. 2016 May-Jun;131(Suppl 2):65-73
Abstract

Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
Cozen ML, Ryan JC, Shen H, et al
Dig Dis Sci
. 2016 Apr 8.
Abstract

FULl-TEXT ARTICLE
Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study.
Younossi ZM, LaLuna LL, Santoro JJ, et al
BMC Gastroenterol. 2016 Apr 4;16(1):45
Paper

FULL-TEXT ARTICLE
Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.
Frimpong JA, D'Aunno T.
Subst Abuse Treat Prev Polic
y
. 2016 Apr 1;11(1):13..

Paper

High-impact hepatitis C virus testing for injection drug users in an urban ED.
Anderson ES, Pfeil SK, Deering LJ, et al

Am J Emerg Med
. 2016 Mar 3.
Abstract

Presence of hepatitis C (HCV) infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation.
Sayiner M, Wymer M, Golabi P, et al
Aliment Pharmacol Ther
. 2016 Mar 15.
Abstract

An assessment of concurrent drug and alcohol use among patients seeking treatment for hepatitis C
Sims OT, Pollio DE, Hong BA, et al  
Ann Clin Psychiatry
. 2016 Feb;28(1):31-6.
Abstract

A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial Enrollment.
Wilder J, Saraswathula A, Hasselblad V, Muir A.
J Natl Med Assoc
. 2016 Feb;108(1):24-29

Abstract

Public health clinic-based hepatitis C testing and linkage to care in Baltimore.
Falade-Nwulia O, Mehta SH, Lasola J, et al
J Viral Hepat. 2016 Feb 3.
Abstract

Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.
Younossi ZM, Bacon BR, Dieterich DT, et al
J Viral Hepat. 2016 Feb 3.
Abstract

Strengthening Screening for HIV, Hepatitis C, and STIs: An Innovative Partnership Between the Health Department and Community Health Centers in New York City.
Terranova E, Tsoi B, Laraque F, Washburn K, Fuld
J. Public Health Rep.
2016 Jan-Feb;131 Suppl 1:5-10.
Abstract

Increasing Prevalence of Cirrhosis among US Adults Aware or Unaware of their Chronic Hepatitis C Virus Infection.
Udompap P, Mannalithara A, Heo N, et al
J Hepatol
. 2016 Jan 22.
Abstract

HCV Prevalence in Asian Americans in California.
Lin ON, Chang C, Lee J,  et al
J Immigr Minor Health
. 2016 Jan 21
Abstract

Treating Hepatitis C in a Ryan White-Funded HIV Clinic: Has the Treatment Uptake Improved in the Interferon-Free Directly Active Antiviral Era?
Cope R, Glowa T, Faulds S, et al
AIDS Patient Care STDS. 2016 Jan 8.
Abstract

Hepatitis C Virus Infection Screening Within Community Health Centers.
Cook N, Turse EP, Garcia AS,  et al 
J Am Osteopath Assoc
. 2016 Jan 1;116(1):6-11.

Abstract

FULL-TEXT ARTICLE
Notes from the Field: Hepatitis C Outbreak in a Dialysis Clinic - Tennessee, 2014.
Muleta D, Kainer MA, Moore-Moravian L,  et al
MMWR Morb Mortal Wkly Rep
. 2016 Jan 1;64(50-51):1386-7
Paper

The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics.
Rein DB, Borton J, Liffmann DK, Wittenborn JS.
Hepatology
. 2015 Dec 28.
Abstract

An evaluation of hepatitis C knowledge and correlations with health belief model constructs among African American "baby boomers".
Rashrash ME, Maneno MK, Wutoh AK, et al

J Infect Public Healt
h
. 2015 Dec 16.

Abstract

The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.
Durham DP, Skrip LA, Bruce RD, et al;  
Clin Infect Dis
. 2015 Nov 30.
Abstract

High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study.
Petersen T, Townsend K, Gordon LA,  et al

Hepatol Int
. 2015 Nov 26
Abstract

Emergency Department Screening for Hepatitis C Virus: Geographic Reach and Spatial Clustering in Central Alabama.
Donnelly JP, Franco R, Wang HE, Galbraith JW.
Clin Infect Dis
. 2015 Nov 26. pii: civ984.
Abstract

FULL-TEXT ARTICLE
Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs.
Ward JW, Mermin JH.
N Engl J Med
. 2015 Nov 17.
Paper

Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission.
Young KL, Huang W, Horsburgh CR, et al
J Viral Hepat. 2015 Nov 17.
Abstract

Factors Associated with Hepatitis C Knowledge Before and After an Educational Intervention among Vietnamese Americans.
Lee S, Zhai S, Zhang GY,
Clin Med Insights Gastroenterol. 2015 Oct 29;8:45-53.
Abstract

Show Me Echo - Hepatitis C: A telemedicine mentoring program for patients with hepatitis C in underserved and rural areas in Missouri as a model in developing countries.
Tahan V, Almashhrawi A, Mutrux R, Ibdah JA.
Turk J Gastroenterol
. 2015 Oct 26.

Abstract

Costs and consequences: Hepatitis C seroprevalance in the military and its impact on potential screening strategies.
Brett-Major DM, Frick KD, Malia JA, et al
Hepatology. 2015 Oct 20.
Abstract

Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas.
Jayasekera CR, Perumpail RB, Chao DT, et al
Dig Dis Sci
. 2015 Oct 14
Abstract

FULL-TEXT ARTICLE
New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison.
Poonsapaya JM, Einodshofer M, Kirkham HS,   et al
Cost Eff Resour Alloc
. 2015 Oct 6;13:17.
Paper

Project P.E.A.C.H. (Pathway and Education Toward Adherence and Completion in Hepatitis C Therapy): A Nurse-Driven Evidence-Based Protocol.
Redulla RR, Reddy KR, Faust TW, Dudley-Brown S
Gastroenterol Nurs. 2015 Sep-Oct;38(5):369-78
Abstract

Hepatitis C Infection Among Hispanics in California.
Cummins CA, Erlyana E, Fisher DG, Reynolds GL.
J Addict Dis
. 2015 Sep 15:
Abstract

Hepatitis C Virus in the US Military Retiree Population: To Screen, or Not to Screen?
Laufer CB, Carroll MB.

J Clin Med Res
. 2015 Oct;7(10):757-61.
Abstract

The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C.
Bickerstaff C.
Expert Rev Pharmacoecon Outcomes Res
. 2015 Aug 10:1-14
Abstract

Access to Costly New Hepatitis C Drugs: Medicine, Money and Advocacy.
Trooskin SB, Reynolds H, Kostman JR.
Clin Infect Dis. 2015 Aug 12.
Abstract

Dialysis-requiring acute kidney injury among hospitalized adults with documented hepatitis C Virus infection: a nationwide inpatient sample analysis.
Nadkarni GN, Patel A, Simoes PK, et al
J Viral Hepat
. 2015 Jul 20.
Abstract

Health Beliefs and Co-morbidities Associated with Appointment-Keeping Behavior Among HCV and HIV/HCV Patients.
Pundhir P, North CS, Fatunde O, Jain MK.
J Community Health
. 2015 Jul 16.
Abstract

Towards a more accurate estimate of the prevalence of hepatitis C in the United States.
Edlin BR, Eckhardt BJ, Shu MA,  et al
Hepatology
. 2015 Jul 14.
Abstract

Underascertainment of Acute Hepatitis C Virus Infections in the U.S. Surveillance System: A Case Series and Chart Review.
Onofrey S, Aneja J, Haney GA, Nagami EH, et al
Ann Intern Med. 2015 Jun 30.
Abstract

The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
Safo SA, Batchelder A, Peyser D, Litwin A.
Harm Reduct J. 2015 Jun 20;12(1):20.
Abstract

"Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment.

Batchelder AW, Peyser D, Nahvi S, et akl
Drug Alcohol Depend
. 2015 Jun 9.
Abstract

Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetes.
Watt GP, Vatcheva KP, Beretta Let al,
Epidemiol Infect
. 2015 Jun 19:
Abstract

Costs and absence of HCV-infected employees by disease stage.
Baran RW, Samp JC, Walker DR,  et al
J Med Econ
. 2015 Jun 5:1-13|

Abstract

Implementing hospital-based baby boomer hepatitis c virus screening and linkage to care: Strategies, results, and costs.
Turner BJ, Taylor BS, Hanson JT,  et al
J Hosp Med. 2015 May 29.
Abstract

Update on Hepatitis C: epidemiology, treatment and resistance to antiviral therapies.
Ness E, Kowdley KV.
Minerva Gastroenterol Dietol
. 2015 May 20.
Abstract

Effect of Gender on the Response to Hepatitis C Treatment in an Inner-City Population.
Simoes P, Asaad A, Abed J,  et al
Womens Health Issues. 2015 May-Jun;25(3):289-293.
Abstract

FULL-TEXT ARTICLE
Identification and Linkage to Care of HCV-Infected Persons in Five Health Centers - Philadelphia, Pennsylvania, 2012-2014.
Coyle C, Viner K, Hughes E,  et al
MMWR Morb Mortal Wkly Rep
. 2015 May 8;64(17):459-463.
Paper

Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.
Suryaprasad A, Basavaraju SV, Hocevar SN,  et al
Am J Transplant. 2015 May 5
Abstract

Implementing Updated Recommendations on Hepatitis C Virus Screening: Translating Federal Guidance Into State Practice.
Martin EG, Norcott AM, Khalid H, OʼConnell DA.
J Public Health Manag Pract
. 2015 Apr 22
Abstract

Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004-2011.
Tong X, Spradling PR.
J Viral Hepat. 2015 Apr 20.
Abstract

FULL-TEXT ARTICLE
Spatiotemporal Analysis of Hepatitis C Virus Infection.
Shulla A, Randall G.
PLoS Pathog
. 2015 Mar 30;11(3):e1004758
Paper

Bacteremia in hemodialysis patients with hepatitis C.
Chebrolu P, Colombo RE, Baer S,  et al
Am J Med Sci
. 2015 Mar;349(3):217-21
Abstract

Lack of Health Insurance Limits the Benefits of Hepatitis C Virus Screening: Insights from the National Health and Nutrition Examination Hepatitis C Follow-Up Study.
Ditah I, Al Bawardy B, Gonzalez HC,  et al
Am J Gastroenterol. 2015 Mar 10.
Abstract

Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in Medicare patients.
Chirikov VV, Shaya FT, Howell CD.
Hepatology
. 2015 Mar 7.
Abstract

FULL-TEXT ARTICLE
Transmission of hepatitis C virus associated with surgical procedures - New Jersey 2010 and Wisconsin 2011.
Apostolou A, Bartholomew ML, Greeley R et al
MMWR Morb Mortal Wkly Rep
. 2015 Feb 27;64(7):165-7
0.
Paper

Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program.
Trooskin SB, Poceta J, Towey CM,  et al.

J Gen Intern Med
. 2015 Feb
Abstract

Cost-effectiveness of hepatitis C treatment for patients in early stages of liver disease.
Leidner AJ, Chesson HW, Xu F, et al
Hepatology. 2015 Feb 11
Abstract

"Test, Listen, Cure" (TLC) Hepatitis C Community Awareness Campaign.
Coughlin SS.
JMIR Res Protoc. 2015 Feb 6;4(1):e13.
Abstract

Reasons for HCV non-treatment in underserved African Americans: Implications for treatment with new therapeutics.
Schaeffer S, Khalili M.
Ann Hepatol. 2015 Mar-Apr 2015;14(2):234-2
Abstract

A Window of Opportunity: Maximizing the Effectiveness of New HCV Regimens in the United States With the Expansion of the Affordable Care Act.
Haley SJ, Kreek MJ.
Am J Public Health. 2015 Jan 20:e1-e7
Abstract

Hepatitis C Virus Antibody Prevalence, Demographics and Associated Factors among Persons Screened at Hawai'i Community-based Health Settings, 2010-2013.
Takeuchi LC, Pham TK, Katz AR.
Hawaii J Med Public Health
. 2015 Jan;74(1):9-15.

Abstract

FULL=TEXT ARTICLE
HIV and Hepatitis C Mortality in Massachusetts, 2002-2011: Spatial Cluster and Trend Analysis of HIV and HCV Using Multiple Cause of Death.
Meyers DJ, Hood ME, Stopka TJ.
PLoS One. 2014 Dec 11;9(12):e114822.
Paper

Provider Workforce Assessment in a Rural Hepatitis C Epidemic: Implications for Scale-up of Antiviral Therapy.
Westergaard RP, Stockman LJ, Hyland HA,  et al
J Prim Care Community Health. 2014 Nov 24
Abstract

Utility of Evaluating HCV in an Uninsured Population.
Donepudi I, Paredes A, Hubbard S, et al
Dig Dis Sci. 2014 Nov 5
Abstract

Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade.
Talaat N, Yapali S, Fontana RJ, et al  
J Viral Hepat. 2014 Oct 14.

Abstract

Risk for Hepatitis B and C Virus Transmission in Nail Salons and Barbershops and State Regulatory Requirements to Prevent Such Transmission in the United States.
Yang J, Hall K, Nuriddin A, Woolard D.
J Public Health Manag Pract
. 2014 November/December;20(6):E20-E30

Abstract

Age Cohort Differences in Illicit Drug Use and HCV among African American Substance Users.
Whitehead NE, Hearn L, Trenz RC,  et al
J Addict Dis
. 2014 Oct 9:0.

Abstract

Hospitalizations and costs associated with hepatitis C and advanced liver disease continue to increase.
Xu F, Tong X, Leidner AJ.
Health Aff (Millwood)
. 2014 Oct 1;33(10):1728-35.
Abstract

Impact of Completing Chronic Hepatitis C (CHC) Treatment on Post-Therapy Healthcare Cost.
Tandon N, Balart L, Laliberté F, et al
J Med Econ. 2014 Sep 12:1-26.
Abstract

Current Practices of Screening for Incident Hepatitis C Virus Infection among HIV- Infected, HCV-Uninfected Individuals in Primary Care.
Freiman JM, Huang W, White L,  et al

Clin Infect Dis
. 2014 Sep 3.
Abstract

Hepatitis C in African Americans.
Saab S, Jackson C, Nieto DO  et al
Am J Gastroenterol
. 2014 Sep 2
.
Abstract

Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department.
Galbraith JW, Franco RA, Donnelly JP,  et al
Hepatology
. 2014 Sep 1
Abstract

Follow-up testing for hepatitis C virus infection: an analysis of Massachusetts surveillance data, 2007-2010.
Barton K, Church D, Onofrey S, Cocoros N, DeMaria A Jr
Public Health Rep
. 2014 Sep;129(5):403-7.
Abstract

Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels.
Smith BD, Yartel AK.
Am J Prev Med
. 2014 Sep;47(3):233-41.
Abstract

Ending hepatitis C in the United States: the role of screening.
Coffin PO, Reynolds A.
Hepat Med. 2014 Jul 3;6:79-87.
Abstract

Impact of Race/Ethnicity and Gender on HCV Screening and Prevalence Among US Veterans in Department of Veterans Affairs Care.
Backus LI, Belperio PS, Loomis TP, Mole LA.
Am J Public Health. 2014 Sep;104 Suppl 4:S555-61.
Abstract

The changing burden of hepatitis C virus infection in the United States: model-based predictions.
Kabiri M, Jazwinski AB, Roberts MS,  et al
Ann Intern Med
. 2014 Aug 5;161(3):170-80.
Abstract

Medication use and medical comorbidity in patients with chronic hepatitis C from a US commercial claims database: high utilization of drugs with interaction potential.
Lauffenburger JC, Mayer CL, Hawke RL, et al
Eur J Gastroenterol Hepatol
. 2014 Jul 10.
Abstract

Trends in HCV RNA testing among HCV antibody positive persons in care, 2003-2010.
Spradling PR, Tong X, Rupp L, et al
Clin Infect Dis
. 2014 Jul 2
Abstract

Estimating the true prevalence of hepatitis C in Rhode Island.
Kinnard EN, Taylor LE, Galárraga O, Marshall BD.
R I Med J (2013)
. 2014 Jul 1;96(7):19-24
Abstract

HCV among The Miriam Hospital and Rhode Island Hospital Adult ED Patients.
Merchant RC, Baird JR, Liu T, Taylor LE.
R I Med J (2013). 2014 Jul 1;96(7):35-9.
Abstract

Substance use and hepatitis C: An ecological momentary assessment study.
Phillips KA, Epstein DH, Vahabzadeh M,  et al
Health Psychol
. 2014 Jul;33(7):710-9.

Abstract


FULL TEXT ARTICLE

Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort.
Tracy D, Hahn JA, Fuller Lewis C, et al
BMJ Open
. 2014 May 29;4(5):e004988
Paper

Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States.
Younossi ZM, Otgonsuren M, Henry L, et al
J Viral Hepat. 2014 May 12.
Abstract

FULL-TEXT ARTICLE
Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model - Arizona and Utah, 2012-2014.
Mitruka K, Thornton K, Cusick S,  et al
MMWR Morb Mortal Wkly Rep. 2014 May 9;63(18):393-8.
Paper

Hepatitis B Virus and Hepatitis C Virus Infections in United States-Bound Refugees from Asia and Africa.
Mixson-Hayden T, Lee D, Ganova-Raeva L
Am J Trop Med Hyg. 2014 Apr 14.

Abstract

FULL-TEXT ARTICLE
Rapid hepatitis C testing among persons at increased risk for infection - Wisconsin, 2012-2013.
Stockman LJ, Guilfoye SM, Benoit AL,
MMWR Morb Mortal Wkly Rep. 2014 Apr 11;63(14):309-11.
Paper

Racial Disparities in the Proportion of Current, Unresolved Hepatitis C Virus Infections in the United States, 2003-2010.
Liu G, Holmberg SD, Kamili S, Xu F.
Dig Dis Sci
. 2014 Feb 27.
Abstract

Deaths among People with Hepatitis C in New York City, 2000 - 2011.
Pinchoff J, Drobnik A, Bornschlegel K,  et al
Clin Infect Dis
. 2014 Feb 12

Abstract

Hepatitis C screening trends in a large integrated health system.
Linas BP, Hu H, Barter DM, Horberg M.
Am J Med
. 2014 Jan 28. pii: S0002-9343(14)00078-3
Abstract

Distinct Features in Natural History and Outcomes of Acute Hepatitis C.
Bunchorntavakul C, Jones LM, Kikuchi M, et al
J Clin Gastroenterol
. 2014 Jan 27

Abstract

A pharmacist-managed telemedicine clinic for hepatitis C care: a descriptive analysis
You A, Kawamoto J, Smith JP.
J Telemed Telecare. 2014 Jan 10.
Abstract

Prevalence of Hepatitis C Virus Infection in US Hispanic/Latino Adults: Results from the NHANES 2007-2010 and HCHS/SOL Studies.
Kuniholm MH, Jung M, Everhart JE, et al
J Infect Dis
.
2014 Jan 13
Abstract

The Spectrum of Undiagnosed Hepatitis C Virus Infection in a US HIV Clinic.
Taylor LE, Foont JA, Delong AK,  et al
AIDS Patient Care STDS
. 2014 Jan;28(1):4-9.
Abstract

HCV and HBV Testing Acceptability and Knowledge among Urban Emergency Department Patients and Pharmacy Clients.
Calderon Y, Cowan E, Schramm C, et al
Prev Med. 2013 Dec 29
Abstract

During chronic HCV infection NCR dependent NK cytolytic activity directed at HCV is associated with liver inflammation, African American Race, IL28B genotype and response to PegIFN/RBV therapy.
Meng Q, Rani MR, Sugalski JM,  et al
J Infect Dis
. 2013 Dec 2.
Abstract

Hepatitis C virus: An overview for dental health care providers.
Klevens RM, Moorman AC.
J Am Dent Assoc
. 2013 Dec;144(12):1340-7.

Abstract

The Changing Epidemiology of Hepatitis C Virus Infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.
Ditah I, Ditah F, Devaki P, et al
J Hepatol
. 2013 Nov 27.

Abstract

Awareness of Biologically Confirmed HCV Among a Community Residing Sample of Drug Users in Baltimore City.
Whitehead NE, Hearn LE, Marsiske M,  et al
J Community Health
. 2013 Oct 31.
Abstract

Less-Established Risk Factors Are Common in Asian Americans with Hepatitis C Virus: A Case-Controlled Study.
Kin KC, Lin B, Chaung KT, Ha NB,  et al
Dig Dis Sci
. 2013 Oct 1
Abstract

Characterization of hepatitis C infection in tuberculosis patients in an urban city in the USA.
Campo M, Shrestha A, Oren E, Thiede H,  et al
Epidemiol Infect. 2013 Sep 25:1-8.

Abstract

Prevalence of HCV Infection Among Clients in Community-Based Health Settings in Hawaii, 2002-2010: Assessing Risk Factors.
Porter JC, Lusk HM, Katz AR.
Am J Public Health. 2013 Sep 12

Abstract

Many Patients with IL28B Genotypes Associated with Response to Therapy are Ineligible for Treatment Because of Comorbidities.
Kanwal F, White DL, Tavakoli-Tabasi S, et al
 Clin Gastroenterol Hepatol
. 2013 Aug 23.
Abstract


Hospitalizations due to hepatitis C in Los Angeles County, 2007-2009: case characteristics and factors associated with mortality.
Sie L, Gatto NM, Bancroft E.
J Viral Hepat
. 2013 Sep;20(9):628-37.
Abstract

The Effect of Hepatitis C Treatment Response on Medical Costs: A Longitudinal Analysis in an Integrated Care Setting.
Manos MM, Darbinian J, Rubin J,  et al
J Manag Care Pharm
. 2013 July/August;19(6):438-447
Abstract

Perceptions of drug users regarding Hepatitis C screening and care: a qualitative study.
Jordan AE, Masson CL, Mateu-Gelabert P, et al
Harm Reduct J. 2013 Jun 20;10(1):10.
Abstract

Indications for Testing Among Reported Cases of Hepatitis C Virus Infection From Enhanced Hepatitis Surveillance Sites in the United States, 2004-2010.
Mahajan R, Liu SJ, Klevens RM, Holmberg SD.
AmJ Public Health
. 2013 Jun 13
Abstract

FULL-TEXT PDF ARTICLE
Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection.
Fusfeld L, Aggarwal J, Dougher C, Vera-Llonch M,  et al
BMC Infect Dis
. 2013 May 23;13(1):234.
Paper

FULL-TEXT ARTICLE
Current and Future Disease Progression of the Chronic HCV Population in the United States.
Zalesak M, Francis K, Gedeon A,  et al 
PLoS One
. 2013 May 21;8(5):e63959
Paper

FULL-TEXT ARTICLE
Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U, S.. Sites, 2005-2011.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):357-61.
Paper

Updates of Lifetime Costs of Care and Quality of Life Estimates for HIV-Infected Persons in the United States: Late Versus Early Diagnosis and Entry into Care.
Farnham PG, Gopalappa C, Sansom SL, et al
J Acquir Immune Defic Syndr. 2013 Apr 22
Abstract

Non-invasive serum fibrosis markers for screening and staging chronic hepatitis C virus (HCV) patients in a large U.S. cohort.
Holmberg SD, Lu M, Rupp LB,  et al
Clin Infect Dis. 2013 Apr 16
Abstract

FULL-TEXT ARTICLE
Cost-effectiveness analysis of risk-factor guided and birth-cohort screening for chronic hepatitis C infection in the United States.
Liu S, Cipriano LE, Holodniy M,  et al
PLoS One. 2013;8(3):e58975.
Paper

Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status.
Stephens DB, Havens JR.
J Stud Alcohol Drugs
. 2013 May;74(3):386-95.
Abstract

The Hepatitis C Self-Management Program: Sustainability of Primary Outcomes at 1 Year.
Groessl EJ, Ho SB, Asch SM,  et al
Health Educ Behav
. 2013 Feb 27
Abstract

Cost-Effectiveness of Screening for Chronic Hepatitis C Infection in the United States.
Eckman MH, Talal AH, Gordon SC,  et al
Clin Infect Dis
. 2013 Feb
Abstract

Hepatitis Outreach Network: A Practical Strategy for Hepatitis Screening with Linkage to Care in Foreign Born communities.
Perumalswami PV, Factor SH, Kapelusznik L, et al
J Hepatol
. 2013 Jan 15

Abstract

High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints.
Kin KC, Lin B, Ha NB,  et al
J Clin Gastroenterol
. 2012 Oct 18.
Abstract

The Impact of Ethnicity on Hepatitis C Virus Treatment Decisions and Outcomes.
Lisker-Melman M, Walewski JL.
Dig Dis Sci. 2012 Oct 12
Abstract

Distribution of hepatitis C virus genotypes in a diverse US integrated health care population.
Manos MM, Shvachko VA, Murphy RC,  et al

J Med Virol
. 2012 Nov;84(11):1744-50
Abstract

Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States.
Tenner CT, Herzog K, Chaudhari S,et al

Int J Clin Pract
. 2012 Oct;66(10):1009-13.
Abstract

Patients' Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection.
Kauf TL, Mohamed AF, Hauber AB, et al

Patient
. 2012 Jul 10.
Abstract

Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles.
Gelberg L, Robertson MJ, Arangua L, et al

Public Health Rep
. 2012 Jul;127(4):407-21.
Abstract

Social networks and HCV viraemia in anti-HCV-positive rural drug users.
Young AM, Jonas AB, Havens JR.

Epidemiol Infect
. 2012 Apr 19:1-10.
Abstract

An analysis of hepatitis C virus-related public inquiries from health professionals: 2009-2010.
Jorgensen CM, Lewis CA, Liu J.
Clin Infect Dis. 2012 Jul;55 Suppl 1:S54-7.
Abstract

Global burden of hepatitis C: considerations for healthcare providers in the United States.
Averhoff FM, Glass N, Holtzman D.
Clin Infect Dis. 2012 Jul;55 Suppl 1:S10-5.
Abstract

Evolving epidemiology of hepatitis C virus in the United States.
Klevens RM, Hu DJ, Jiles R, Holmberg SD.

Clin Infect Dis
. 2012 Jul;55 Suppl 1:S3-9.
Abstract

The Burden of Untreated Hepatitis C Virus Infection: A US Patients' Perspective.
El Khoury AC, Vietri J, Prajapati G.
Dig Dis Sci. 2012 Jun 5
Abstract

Health care-associated hepatitis C virus infections attributed to narcotic diversion.
Hellinger WC, Bacalis LP, Kay RS, et al
Ann Intern Med. 2012 Apr 3;156(7):477-82.
Abstract

Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: A retrospective multicenter study.
Torres HA, Nevah MI, Barnett BJ, et al
J Clin Virol. 2012 Mar 27.
Abstract

Economic burden of hepatitis C-associated diseases in the United States.
El Khoury AC, Klimack WK, Wallace C, Razavi H.
J Viral Hepat. 2012 Mar;19(3):153-60.
Abstract

Assessing educational needs of potential hepatitis C patients at a veterans affairs medical center.
Jennings AR.
Educ Health (Abingdon). 2011 Dec;24(3):532
Abstract

FULL-TEXT ARTICLE
Transmission of hepatitis C virus through transplanted organs and tissue - Kentucky and Massachusetts, 2011.
Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep
. 2011 Dec 23;60:1697-700
Paper

FULL-TEXT ARTCLE
Notes from the Field: Risk Factors for Hepatitis C Virus Infections Among Young Adults --- Massachusetts, 2010
CDC
MMWR Morb Mortal Wkly R
ep. 2011 Oct 28;60:1457-8.
Paper

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study
Lo Re V 3rd, Teal V, Localio AR, et al

Ann Intern Med
. 2011 Sep 20;155(6):353-60.
Abstract

Public Health Implications of Rapid Hepatitis C Screening With an Oral Swab for Community-Based
Organizations Serving High-Risk Populations.
Drobnik A, Judd C, Banach D,  et al

Am J Public Health
. 2011 Sep 22.
Abstract

FULL-TEXT PDF ARTICLE
Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California.
Telles Dias P, Hahn JA, Delwart E,  et al 
BMC Infect Dis
. 2011 Aug 2;11(1):208

Paper

FULL-TEXT ARTICLE
Sexual Transmission of Hepatitis C Virus Among HIV-Infected Men Who Have Sex with Men ---New York City, 2005--2010.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2011 Jul 22;60:945-50
Paper

Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data.
Kershenobich D, Razavi HA, Cooper CL,  et al

Liver Int
. 2011 Jul;31 Suppl 2:4-17.
Abstract

All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population.
El-Kamary SS, Jhaveri R, Shardell MD.

Clin Infect Dis
. 2011 Jun 10.
Abstract

Hepatitis C Virus Genotypes in Clinical Specimens Tested at a National Reference Testing Laboratory in the United States.
Germer JJ, Mandrekar JN, Bendel JL, et al

J Clin Microbiol
. 2011 May 25
Abstract

 

     Conference Reports, Abstracts, and Posters
 
  District of Columbia Partnership for HIV/AIDS Progress (DC PFAP) Subspecialty Clinics: a model for hepatitis C care and research in community clinics serving a predominantly HIV-positive population
Z. Moak, D. Silver, A. Osinusi, et al
(XIX International AIDS Conference)
Abstract
 
 


HCV Epidemiology Main Page   Main New/Newsworthy  Home Page      

National Seroprevalence/Incidence Studies
National Challenges